Bristol-Myers Squibb buy StockNews.com
Start price
29.07.23
/
50%
€55.90
Target price
29.07.24
-
Performance (%)
-19.63%
End price
30.07.24
€44.93
Summary
This prediction ended on 30.07.24 with a price of €44.93. The prediction for Bristol-Myers Squibb disappointed with a performance of -19.63%. StockNews_com has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.19 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 2.075% | 2.075% | 13.529% |
| iShares Core DAX® | -1.862% | -1.624% | 0.645% |
| iShares Nasdaq 100 | -3.322% | 3.321% | 32.004% |
| iShares Nikkei 225® | -2.299% | 3.437% | 51.012% |
| iShares S&P 500 | -1.313% | 2.435% | 23.006% |
Comments by StockNews_com for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten